Incidence of cardiovascular events among tildrakizumab-treated patients with moderate to severe plaque psoriasis: Pooled data from 3 large randomized clinical trials

被引：0
|
作者：
Bissonnette, Robert [1 ]
Fernandez-Penas, Pablo [2 ,3 ]
Puig, Lluis [4 ]
Mendelsohn, Alan M. [5 ]
Rozzo, Stephen J. [5 ]
Menter, Alan [6 ,7 ]
机构：
[1] Innovaderm Res, Montreal, PQ, Canada
[2] Westmead Hosp, Dept Dermatol, Sydney, NSW, Australia
[3] Univ Sydney, Sydney Med Sch, Sydney, NSW, Australia
[4] Univ Autonoma Barcelona, Hosp Santa Creu & St Pau, Barcelona, Spain
[5] 5Sun Pharmaceut Ind Inc, Princeton, NJ USA
[6] Baylor Scott & White, Div Dermatol, Dallas, TX USA
[7] Texas A&M Coll Med, Dallas, TX USA
来源：
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY | 2019年 / 81卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
9796
引用
收藏
页码：AB79 / AB79
页数：1
相关论文
共 50 条
  • [1] Incidence of cardiovascular events among tildrakizumab-treated patients with psoriasis: Pooled data from 3 large randomized clinical trials
    Bissonnette, R.
    Fernandez-Penas, P.
    Puig, L.
    Mendelsohn, A.
    Rozzo, S.
    Menter, A.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 62 - 62
  • [2] Incidence of cardiovascular events among tildrakizumab-treated patients with moderate-to-severe plaque psoriasis: pooled data from three large randomised clinical trials
    Bissonnette, R.
    Fernandez-Penas, P.
    Puig, L.
    Mendelsohn, A. M.
    Rozzo, S. J.
    Menter, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2020, 34 (01) : E21 - E24
  • [3] Incidence of serious gastrointestinal events among tildrakizumab-treated patients with moderate to severe plaque psoriasis: Data from 3 randomized clinical trials
    Gooderham, M.
    Elewski, B.
    Pariser, D.
    Sofen, H.
    Mendelsohn, A.
    Li, Q.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 63 - 63
  • [4] Incidence of Serious Gastrointestinal Events and Inflammatory Bowel Disease Among Tildrakizumab-Treated Patients with Moderate to Severe Plaque Psoriasis: Data from 3 Large Randomized Clinical Trials
    Gooderham, Melinda
    Elewski, Boni E.
    Pariser, David M.
    Sofen, Howard
    Mendelsohn, Alan M.
    Cichanowitz, Nicole
    Li, Qing
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [5] Incidence of serious gastrointestinal events and inflammatory bowel disease among tildrakizumab-treated patients with moderate-to-severe plaque psoriasis: Data from 3 large randomized clinical trials
    Gooderham, Melinda
    Elewski, Boni
    Pariser, David
    Sofen, Howard
    Mendelsohn, Alan
    Cichanowitz, Nicole
    Li, Qing
    la Rosa, Carmen
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB166 - AB166
  • [6] INCIDENCE OF SERIOUS GASTROINTESTINAL EVENTS AND INFLAMMATORY BOWEL DISEASE AMONG TILDRAKIZUMAB-TREATED PATIENTS WITH MODERATE TO SEVERE PLAQUE PSORIASIS: DATA FROM 3 LARGE RANDOMISED CLINICAL TRIALS
    Gooderham, M.
    Elewski, B. E.
    Pariser, D. M.
    Sofen, H.
    Mendelsohn, A. M.
    Cichanowitz, N.
    Li, Q.
    La Rosa, C.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 364 - 364
  • [7] Incidence of cardiovascular events in patients with moderate-to-severe plaque psoriasis treated with tildrakizumab: pooled analysis from a phase 2 and two phase 3 trials
    Bissonnette, R.
    Fernandez-Penas, P.
    Puig, L.
    Peserico, A.
    Fumero, E.
    Mendelsohn, A.
    Rozzo, S.
    Menter, A.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 : 46 - 47
  • [8] INCIDENCE OF SERIOUS GASTROINTESTINAL EVENTS AMONG TILDRAKIZUMAB-TREATED PATIENTS WITH PSORIASIS
    Gooderham, Melinda
    Elewski, Boni E.
    Pariser, David M.
    Sofen, Howard
    Mendelsohn, Alan M.
    Cichanowitz, Nicole
    Li, Qing
    La Rosa, Carmen
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 24 - 24
  • [9] Incidence of serious gastrointestinal events among tildrakizumab-treated patients with psoriasis
    Gooderham, M.
    Elewski, B. E.
    Pariser, D. M.
    Sofen, H.
    Mendelsohn, A. M.
    Rozzo, S. J.
    Li, Q.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2019, 33 (10) : E350 - E352
  • [10] INCIDENCE OF INFECTIONS IN CLINICAL TRIALS OF TILDRAKIZUMAB FOR MODERATE TO SEVERE PLAQUE PSORIASIS
    Crowley, Jeffrey
    Leonardi, Craig
    Sturgill-Koszycki, Sheila
    Menter, Alan
    Mendelsohn, Alan
    Li, Qing
    Cichanowitz, Nicole
    La Rosa, Carmen
    ACTA DERMATO-VENEREOLOGICA, 2018, 98 : 28 - 28
12345